PLS Diagnosis — The 2020 Consensus Criteria

PLS has no single definitive test. Diagnosis is a clinical process based on the pattern of symptoms, examination findings, and — critically — the passage of time. For most people, the path from first symptoms to a confirmed diagnosis takes between three and five years.

Why diagnosis takes time

The central challenge in diagnosing PLS is that its early presentation — progressive stiffness and weakness with upper motor neuron signs — is shared by several other conditions, most significantly by ALS. Approximately 23% of people who initially present with pure upper motor neuron symptoms and receive a working PLS diagnosis will eventually develop lower motor neuron signs and be reclassified as ALS. That reclassification almost always happens within the first four years.

This is not a failure of the diagnostic process — it is the diagnostic process. The longer you have had pure upper motor neuron symptoms without any lower motor neuron involvement, the more confident the diagnosis of PLS becomes. The 2020 consensus criteria formalize this by using time as a core diagnostic criterion.

The median time from symptom onset to diagnosis is 3–5 years. That delay is frustrating, but it reflects the genuine clinical uncertainty that exists early in the disease course. Each follow-up visit that confirms the absence of lower motor neuron signs strengthens the diagnosis.

The 2020 consensus criteria

The current standard for diagnosing PLS is the informal consensus criteria published in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP) in 2020 after an international expert consensus process. These replaced older, more fragmented criteria and have since been validated across large multicenter cohorts.

To receive a PLS diagnosis under the 2020 criteria, you must have all four of the following:

1. Progressive upper motor neuron dysfunction in at least 2 body regions — for example, both legs, or one leg and the bulbar region. The dysfunction must be progressive over time, not static.
2. No active lower motor neuron degeneration — confirmed by EMG (electromyography). The absence of EMG-detectable denervation is a required finding, not just a supporting one.
3. No alternative diagnosis — other conditions that cause a similar upper motor neuron picture must be excluded. This includes hereditary spastic paraplegia (HSP), progressive multiple sclerosis, structural cord lesions (such as cervical myelopathy), and other upper motor neuron disorders.
4. No sensory symptoms — PLS is a pure motor disorder. Sensory involvement points toward a different diagnosis.

Probable vs. definite PLS

The 2020 criteria introduce a two-tier classification based on how long you have had pure upper motor neuron symptoms:

• Probable PLS: all four criteria met, with pure upper motor neuron syndrome persisting for 2 to 4 years from symptom onset. At this stage, some residual uncertainty about ALS conversion remains, but is already substantially reduced compared to the very early phase.
• Definite PLS: all four criteria met, with pure upper motor neuron syndrome persisting for 4 or more years from symptom onset. After 4 years without any lower motor neuron involvement — no fasciculations, no muscle atrophy, normal or near-normal EMG — conversion to ALS is uncommon. A definite PLS diagnosis carries a markedly better prognosis.

The 2020 criteria were validated in a large expert-opinion cohort across multiple centers, and a 2025 Netherlands prospective cohort study further tested them in real-world data, identifying areas for potential refinement in future iterations.

Key tests

EMG (electromyography)

EMG is the most important test in the diagnostic workup for PLS. It measures the electrical activity in muscles and can detect the active denervation that indicates lower motor neuron involvement. In PLS, EMG is normal or shows only very mild, clinically insignificant neurogenic changes — changes insufficient to meet the El Escorial criteria for ALS. Finding active denervation on EMG is the key signal that would shift a diagnosis toward ALS.

Expect EMG to be repeated over time. A single normal result early in the disease course is reassuring but not conclusive. Serial normal EMGs as the years pass are what build toward a definite diagnosis.

MRI of the brain and spine

MRI serves two purposes: ruling out structural and inflammatory conditions that can mimic PLS, and providing supportive positive findings. In PLS, brain MRI may show:

• High T2 signal along the corticospinal tracts — sometimes described as the "wine glass sign" because of its appearance on coronal imaging. This reflects degeneration of the upper motor neuron pathways.
• Motor cortex atrophy — decreased thickness of the primary motor cortex has been documented in PLS (Butman et al., AJNR 2007).
• High T2 signal in the corpus callosum — consistent with the topographic distribution of motor fiber degeneration.

Spinal MRI is important for excluding cervical myelopathy, which can produce a clinical picture that closely resembles PLS.

Genetic testing

Genetic testing is increasingly valuable in the PLS workup, particularly if there is a family history of a similar condition, if symptoms began at an unusually young age, or if hereditary spastic paraplegia is a serious diagnostic consideration. Testing can identify HSP-associated gene variants (such as SPAST, ATL1, and many others), ALS-associated variants (SOD1, C9orf72), and ALS2 gene mutations that cause juvenile PLS. A normal genetic panel does not exclude PLS, but it substantially narrows the differential.

Other blood tests and lumbar puncture

Routine blood work helps exclude metabolic, infectious, and inflammatory causes of upper motor neuron dysfunction. Cerebrospinal fluid analysis may be performed to help rule out inflammatory or infectious myelopathy, though it does not directly confirm PLS.

Differential diagnoses

Before arriving at a PLS diagnosis, your neurologist will need to consider and exclude several conditions that can produce a similar clinical picture:

• Hereditary spastic paraplegia (HSP): A group of inherited conditions that cause progressive leg stiffness and weakness through upper motor neuron degeneration. HSP can be clinically indistinguishable from PLS; genetic testing is the primary way to differentiate them.
• Progressive multiple sclerosis: Progressive MS can produce a pure upper motor neuron syndrome, particularly in primary or secondary progressive forms. MRI, cerebrospinal fluid analysis, and visual evoked potentials help exclude MS.
• Structural cord lesions: Cervical spondylotic myelopathy (compression of the spinal cord by arthritic changes in the neck) is one of the most common mimics of PLS in older adults. MRI of the cervical spine is essential.
• UMN-dominant ALS: The overlap between slowly progressive, UMN-dominant ALS and PLS is the most difficult diagnostic distinction. Time and serial EMG are the primary tools.

What to expect from the diagnostic process

Most people with PLS see multiple neurologists before reaching a confident diagnosis. This is not unusual — it reflects the genuine difficulty of the diagnosis, not inadequate care. A few things that help:

• Seek a neurologist with motor neuron disease experience. Neurologists who regularly see ALS and PLS will be more familiar with the diagnostic criteria and the evolution of the condition over time.
• Keep a record of your symptoms and their timeline. When symptoms started, which body regions were affected first, and how they have evolved matters clinically and is worth documenting carefully.
• Expect serial follow-up. The diagnosis of PLS is not made at a single visit. Regular follow-up allows your neurologist to track whether the clinical picture remains confined to upper motor neurons — which is the key question.
• Ask about the probable vs. definite distinction. If your symptoms have been present for more than two years without lower motor neuron signs, ask your neurologist whether you currently meet criteria for probable PLS and what would move the diagnosis toward definite.